Intrathecal endothelin-1 has antinociceptive effects in rat model of postoperative pain

Eur J Pharmacol. 2012 Dec 15;697(1-3):40-6. doi: 10.1016/j.ejphar.2012.09.035. Epub 2012 Oct 3.

Abstract

Endothelin-1 is known to be a potent vasoconstrictor. Administration of endothelin-1 to the central nervous system (CNS) induces antinociceptive effects. Nociceptive stimuli affect dorsal root ganglion (DRG) neurons and neurons/astrocytes/microglia in the dorsal horn of the spinal cord. Surgical incision in the plantar aspect of the rat hindpaw is a model for postoperative pain, and withdrawal thresholds reportedly decrease around the incision. We hypothesized that intrathecal endothelin-1 would have antinociceptive effects in this model, and affect DRG neurons and microglia/neurons in the dorsal horn. Intrathecal endothelin-1 partially restored the withdrawal threshold (which was decreased by plantar incision). BQ-123, and BQ-788 (specific endothelin ET(A)- and ET(B)-receptor antagonists, respectively) attenuated the increase in withdrawal threshold induced by endothelin-1. Phosphorylation of extracellular signal-regulated kinase (ERK) in DRG neurons and microglial activation/ERK phosphorylation in the dorsal horn were observed following the incision. Endothelin-1 decreased the incision-induced increase in the numbers of phosphorylated ERK-positive neurons in DRG and activated microglia in the dorsal horn, without affecting the numbers of phosphorylated ERK-positive neurons in the dorsal horn. BQ-123 or BQ-788 partially suppressed these endothelin-1-induced alterations. Our results show that the pain threshold, which is decreased by surgical stimuli, is partially restored by intrathecal endothelin-1 through both endothelin ET(A)- and ET(B)- receptors in DRG neurons and microglia in the spinal cord. Endothelin-1 administration to the CNS may be worth considering as a new candidate for the treatment of postoperative pain and to mitigate prolonged periods of pain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics / administration & dosage*
  • Animals
  • Behavior, Animal / drug effects
  • Disease Models, Animal
  • Endothelin-1 / administration & dosage*
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Flavonoids / pharmacology
  • Ganglia, Spinal / drug effects
  • Ganglia, Spinal / metabolism
  • Ganglia, Spinal / physiopathology
  • Injections, Spinal
  • Male
  • Microglia / drug effects
  • Microglia / metabolism
  • Oligopeptides / pharmacology
  • Pain Measurement
  • Pain Threshold / drug effects*
  • Pain, Postoperative / diagnosis
  • Pain, Postoperative / drug therapy*
  • Pain, Postoperative / metabolism
  • Pain, Postoperative / physiopathology
  • Peptides, Cyclic / pharmacology
  • Phosphorylation
  • Piperidines / pharmacology
  • Posterior Horn Cells / drug effects
  • Posterior Horn Cells / metabolism
  • Protein Kinase Inhibitors / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Endothelin A / drug effects
  • Receptor, Endothelin A / metabolism
  • Receptor, Endothelin B / drug effects
  • Receptor, Endothelin B / metabolism
  • Time Factors

Substances

  • Analgesics
  • Endothelin-1
  • Flavonoids
  • Oligopeptides
  • Peptides, Cyclic
  • Piperidines
  • Protein Kinase Inhibitors
  • Receptor, Endothelin A
  • Receptor, Endothelin B
  • BQ 788
  • Extracellular Signal-Regulated MAP Kinases
  • cyclo(Trp-Asp-Pro-Val-Leu)
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one